Dr. Markus Roggen is founder of both Complex Biotech AG and Controlled Chemistry. Complex Biotech is a Swiss-based analytics and market intelligence company for cannabis and other complex botanical formulations. Controlled Chemistry, a Canadian academic joint venture and R&D service focused on process optimization through AI and next generation analytical chemistry platforms.
Dr. Roggen received his M/Sci degree from Imperial College, London, UK in 2008. He received his PhD in 2012 in organic chemistry at the Federal Institute of Technology in Zürich (ETHZ). And completed a PostDoc in physical organic chemistry at The Scripps Research Institute in La Jolla in 2014. He then entered the cannabis industry in 2014 and since has held executive positions in analytical and production companies. His research into process optimization and analytical methods has been recognized with a number of awards, ElSohley Award of the ACS, Cannabis Scientist Power List 2020, 2021 & 2022, 40 under 40 by Marijuana Venture Magazine to highlight. Dr. Roggen is also a trusted advisor and mentor to multiple startups, startup accelerators and organizations.
Dr. Roggen’s research into cannabis spans optimization of extraction processes using machine learning, investigating the chemistry of cannabis combustion, discovering impurities and their implications in cannabis products, and proposing solutions to enhance efficiency in chemical analytics. His work impacts both the scientific community and the general public by enhancing knowledge, ensuring product safety, and improving production/consumption practices of cannabis.
